Results 131 to 140 of about 5,934 (217)

Lysergic acid diethylamide-derived excitatory/inhibitory ratio change enhances global synchrony in functional brain dynamics. [PDF]

PLoS Comput Biol
Zhang L, Shi W, Zhao Z, Wang Z, Chu C, Zhao B, Zhang J, Liu Q, Lan Y, Jiang T.   +9 more
europepmc   +1 more source

Synthetic Strategies toward Lysergic Acid Diethylamide: Ergoline Synthesis via α-Arylation, Borrowing Hydrogen Alkylation, and C-H Insertion. [PDF]

J Org Chem, 2023
Tuck JR, Dunlap LE, Olson DE.
europepmc   +1 more source

A randomised placebo-controlled study of the effects of lysergic acid diethylamide microdosing (15 μg) on pain perception in healthy volunteers. [PDF]

Br J Pain
Cavarra M, Hutten NRPW, Schepers J, Mason NL, Theunissen EL, Liechti ME, Kuypers KPC, Bonnelle V, Feilding A, Ramaekers JG.   +9 more
europepmc   +1 more source

Return of the lysergamides. Part VII: Analytical and behavioural characterization of 1-valeroyl-d-lysergic acid diethylamide (1V-LSD). [PDF]

Drug Test Anal, 2022
Brandt SD, Kavanagh PV, Westphal F, Pulver B, Morton K, Stratford A, Dowling G, Halberstadt AL.   +7 more
europepmc   +1 more source

Lysergic Acid Diethylamide (LSD) and the Heart: Exploring the Potential Impacts of LSD on Cardiovascular Function. [PDF]

Cureus
Suleria A, Verma S, Arya K, Stoltzfus MT, Gupta I, Singh B, Shaik T.   +6 more
europepmc   +1 more source

Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. [PDF]

Proc Natl Acad Sci U S A, 2021
De Gregorio D, Popic J, Enns JP, Inserra A, Skalecka A, Markopoulos A, Posa L, Lopez-Canul M, He Q, Lafferty CK, Britt JP, Comai S, Aguilar-Valles A, Sonenberg N, Gobbi G.   +14 more
europepmc   +1 more source

Exploring Gender-Themed Lysergic Acid Diethylamide Experiences: A Subreddit Analysis. [PDF]

Psychedelic Med (New Rochelle)
Katkar R, Perez AM, Altinay M, Barnett BS.   +3 more
europepmc   +1 more source

Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline. [PDF]

Neuropsychopharmacology, 2022
De Gregorio D, Inserra A, Enns JP, Markopoulos A, Pileggi M, El Rahimy Y, Lopez-Canul M, Comai S, Gobbi G.   +8 more
europepmc   +1 more source

Pharmacokinetics and pharmacodynamics of sublingual microdosed lysergic acid diethylamide in healthy adult volunteers. [PDF]

J Psychopharmacol
Morse JD, Jeong SH, Murphy RJ, Muthukumaraswamy SD, Sumner RL.   +4 more
europepmc   +1 more source

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers. [PDF]

J Psychopharmacol, 2021
Ramaekers JG, Hutten N, Mason NL, Dolder P, Theunissen EL, Holze F, Liechti ME, Feilding A, Kuypers KP.   +8 more
europepmc   +1 more source